10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine

C174H124N28O2S2Si2 — CID 158237204

IUPAC10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine
SMILESCC1(C)c2ccccc2N(c2cc(-c3ncncn3)cc3c(N4c5ccccc5C(C)(C)c5ccccc54)cc(-c4ncccn4)cc23)c2ccccc21.C[Si]1(C)c2ccccc2N(c2cc(-c3ncncn3)cc3c(N4c5ccccc5[Si](C)(C)c5ccccc54)cc(-c4ncccn4)cc23)c2ccccc21.c1cnc(-c2cc(N3c4ccccc4Oc4ccccc43)c3cc(-c4ncncn4)cc(N4c5ccccc5Oc5ccccc54)c3c2)nc1.c1cnc(-c2cc(N3c4ccccc4Sc4ccccc43)c3cc(-c4ncncn4)cc(N4c5ccccc5Sc5ccccc54)c3c2)nc1
InChIInChI=1S/C47H37N7.C45H37N7Si2.C41H25N7O2.C41H25N7S2/c1-46(2)34-14-5-9-18-38(34)53(39-19-10-6-15-35(39)46)42-26-30(44-49-22-13-23-50-44)24-32-33(42)25-31(45-51-28-48-29-52-45)27-43(32)54-40-20-11-7-16-36(40)47(3,4)37-17-8-12-21-41(37)54;1-53(2)40-18-9-5-14-34(40)51(35-15-6-10-19-41(35)53)38-26-30(44-47-22-13-23-48-44)24-32-33(38)25-31(45-49-28-46-29-50-45)27-39(32)52-36-16-7-11-20-42(36)54(3,4)43-21-12-8-17-37(43)52;2*1-5-14-36-30(10-1)47(31-11-2-6-15-37(31)49-36)34-22-26(40-43-18-9-19-44-40)20-28-29(34)21-27(41-45-24-42-25-46-41)23-35(28)48-32-12-3-7-16-38(32)50-39-17-8-4-13-33(39)48/h2*5-29H,1-4H3;2*1-25H
InChIKeyGFCLNGSAGSXPBX-UHFFFAOYSA-N
MW2759.41 g/mol
LogP41.04
Rot. Bonds16

About 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine

10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine (PubChem CID 158237204) has the molecular formula C174H124N28O2S2Si2 and a molecular weight of 2759.41 g/mol. Its IUPAC name is 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine.

Molecular Properties

Compound Name10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine
PubChem CID158237204
Molecular FormulaC174H124N28O2S2Si2
Molecular Weight2759.41 g/mol
Exact Mass2756.94
IUPAC Name10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine
SMILESCC1(C)c2ccccc2N(c2cc(-c3ncncn3)cc3c(N4c5ccccc5C(C)(C)c5ccccc54)cc(-c4ncccn4)cc23)c2ccccc21.C[Si]1(C)c2ccccc2N(c2cc(-c3ncncn3)cc3c(N4c5ccccc5[Si](C)(C)c5ccccc54)cc(-c4ncccn4)cc23)c2ccccc21.c1cnc(-c2cc(N3c4ccccc4Oc4ccccc43)c3cc(-c4ncncn4)cc(N4c5ccccc5Oc5ccccc54)c3c2)nc1.c1cnc(-c2cc(N3c4ccccc4Sc4ccccc43)c3cc(-c4ncncn4)cc(N4c5ccccc5Sc5ccccc54)c3c2)nc1
InChIInChI=1S/C47H37N7.C45H37N7Si2.C41H25N7O2.C41H25N7S2/c1-46(2)34-14-5-9-18-38(34)53(39-19-10-6-15-35(39)46)42-26-30(44-49-22-13-23-50-44)24-32-33(42)25-31(45-51-28-48-29-52-45)27-43(32)54-40-20-11-7-16-36(40)47(3,4)37-17-8-12-21-41(37)54;1-53(2)40-18-9-5-14-34(40)51(35-15-6-10-19-41(35)53)38-26-30(44-47-22-13-23-48-44)24-32-33(38)25-31(45-49-28-46-29-50-45)27-39(32)52-36-16-7-11-20-42(36)54(3,4)43-21-12-8-17-37(43)52;2*1-5-14-36-30(10-1)47(31-11-2-6-15-37(31)49-36)34-22-26(40-43-18-9-19-44-40)20-28-29(34)21-27(41-45-24-42-25-46-41)23-35(28)48-32-12-3-7-16-38(32)50-39-17-8-4-13-33(39)48/h2*5-29H,1-4H3;2*1-25H
InChIKeyGFCLNGSAGSXPBX-UHFFFAOYSA-N
XLogP41.04
TPSA302.18 Ų
H-Bond Donors
H-Bond Acceptors32
Rotatable Bonds16
Heavy Atoms208
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002759.41
LogP ≤ 541.04
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine?
The IUPAC name of 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine (CID 158237204) is 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine.
What is the SMILES notation for 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine?
The canonical SMILES for 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine is CC1(C)c2ccccc2N(c2cc(-c3ncncn3)cc3c(N4c5ccccc5C(C)(C)c5ccccc54)cc(-c4ncccn4)cc23)c2ccccc21.C[Si]1(C)c2ccccc2N(c2cc(-c3ncncn3)cc3c(N4c5ccccc5[Si](C)(C)c5ccccc54)cc(-c4ncccn4)cc23)c2ccccc21.c1cnc(-c2cc(N3c4ccccc4Oc4ccccc43)c3cc(-c4ncncn4)cc(N4c5ccccc5Oc5ccccc54)c3c2)nc1.c1cnc(-c2cc(N3c4ccccc4Sc4ccccc43)c3cc(-c4ncncn4)cc(N4c5ccccc5Sc5ccccc54)c3c2)nc1.
What is the InChIKey of 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine?
The InChIKey is GFCLNGSAGSXPBX-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H37N7.C45H37N7Si2.C41H25N7O2.C41H25N7S2/c1-46(2)34-14-5-9-18-38(34)53(39-19-10-6-15-35(39)46)42-26-30(44-49-22-13-23-50-44)24-32-33(42)25-31(45-51-28-48-29-52-45)27-43(32)54-40-20-11-7-16-36(40)47(3,4)37-17-8-12-21-41(37)54;1-53(2)40-18-9-5-14-34(40)51(35-15-6-10-19-41(35)53)38-26-30(44-47-22-13-23-48-44)24-32-33(38)25-31(45-49-28-46-29-50-45)27-39(32)52-36-16-7-11-20-42(36)54(3,4)43-21-12-8-17-37(43)52;2*1-5-14-36-30(10-1)47(31-11-2-6-15-37(31)49-36)34-22-26(40-43-18-9-19-44-40)20-28-29(34)21-27(41-45-24-42-25-46-41)23-35(28)48-32-12-3-7-16-38(32)50-39-17-8-4-13-33(39)48/h2*5-29H,1-4H3;2*1-25H.
What are the key properties of 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine?
10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine has a molecular weight of 2759.41 g/mol, XLogP of 41.04, 16 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[5-(9,9-dimethylacridin-10-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-9,9-dimethylacridine;5-[5-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[5-phenothiazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenothiazine;10-[5-phenoxazin-10-yl-3-pyrimidin-2-yl-7-(1,3,5-triazin-2-yl)naphthalen-1-yl]phenoxazine is sourced from PubChem (CID 158237204), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).